Nuclearelectrica and Framatome take the next step in producing cancer-fighting medical isotope in Romania
Nuclearelectrica and Framatome have announced the successful outcome of the feasibility study which assessed the possibility of producing medical isotope Lutetium-177 (Lu-177) at the Cernavoda nuclear power plant in Romania. Lutetium-177 is used for a variety of lifesaving cancer treatments. [&#8230;]